Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive Nicotine Substitution for Smoking Reduction Maintenance
NCT06554873Phase 3Completed
- Sponsor
- Rose Research Center
- Start
- Aug 2024
- Primary completion
- Dec 2025
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicotine patch, NJOY, on! in Tobacco Use Disorder (TUD), sponsored by Rose Research Center. Started Aug 2024; status: completed.
02
Drugs
nicotine patchNJOYon!
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT06554873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06554873.